Amanta Healthcare IPO
GMP, Subscription, Price, Dates & Financial Details
Pharmaceutical & Drugs
Incorporated in December 1994, Amanta Healthcare Limited is a pharmaceutical company specializing in the development, manufacturing, and marketing of sterile liquid products. The company focuses on parenteral formulations, packaged using Aseptic Blow-Fill-Seal (ABFS) and Injection Stretch Blow…
Open Date
Mon, 01 Sep 2025
Close Date
Wed, 03 Sep 2025
Price Band
₹ 120 – 126
Lot Size
119
Issue Size
₹ 126.00 Cr
Minimum Investment
₹ 14,994 (119 Shares)
Grey Market Premium Analysis
Day Wise GMP→Unofficial premium quoted in the grey market, tracked daily against the price band cap.
Grey market trading is unregulated. GMP figures are indicative only and should not be the sole basis for investment decisions - treat as a sentiment indicator, not a guarantee.
IPO Details
Amanta Healthcare IPO has successfully completed its IPO process and is now listed on the NSE and BSE. According to the Red Herring Prospectus (RHP), the IPO was a book-built issue with a total issue size of ₹126.00 Crore, comprising a fresh issue of 100.00 Lakh equity shares aggregating to ₹126.00 Crore.
The Amanta Healthcare IPO remained open for subscription from September 01, 2025, to September 03, 2025. The basis of allotment was finalized on September 04, 2025, and the company's shares were listed on the NSE and BSE on September 09, 2025.
The company had fixed the price band at ₹120 to ₹126 per share, with a lot size of 119 shares. Retail investors were required to make a minimum investment of ₹14,994 (based on the upper price band) to apply for one lot.
MUFG Intime India Private Limited served as the registrar to the issue. Beeline Capital Advisors Pvt Ltd acted as the Book Running Lead Managers (BRLMs) to the issue.
With the successful completion of the IPO process, Amanta Healthcare Ltd is now a publicly listed company on the NSE and BSE. Investors can track the company's share price, trading performance, financial results, and corporate announcements through the stock exchanges.
Amanta Healthcare IPO Timeline (Tentative)
- IPO Open Date
- Mon, 01 Sep 25
- IPO Close Date
- Wed, 03 Sep 25
- Basis of Allotment
- Thu, 04 Sep 25
- Initiation of Refunds
- Mon, 08 Sep 25
- Credit of Shares to Demat
- Mon, 08 Sep 25
- Listing Date
- Tue, 09 Sep 25 — NSE & BSE
Open Date
01 September 2025
Close Date
03 September 2025
Basis Of Allotment
04 September 2025
Listing Date
09 September 2025
IPO Subscription
Check Live Subscription →The Amanta Healthcare IPO has received bids for 57,82,80,738 shares against 70,00,000 shares offered, resulting in an overall subscription of 82.61x. the NII category is subscribed 209.42x, Retail Investors 54.98x, and QIBs 35.86x. Within the NII category, BNII is subscribed 226.13x, while SNII is subscribed 176.02x.
QIB
35.86x
NII
209.42x
BNII
226.13x
SNII
176.02x
RII
54.98x
Total
82.61x
IPO Reservations
The Retail Individual Investor (RII) category has the highest allocation with 35,00,000 shares, representing 50% of the total issue. Qualified Institutional Buyers (QIBs) are allocated 0 shares (%), while Non-Institutional Investors (NIIs) receive 15,00,000 shares (21.43%).
| Category | Shares Offered | Shares Offered % |
|---|---|---|
| 2,000,000 | 28.57% | |
| Non-Institutional | 1,500,000 | 21.43% |
| BNII | 1,000,000 | 14.29% |
| SNII | 500,000 | 7.14% |
| Retail Investors | 3,500,000 | 50% |
| Total | 7,000,000 | 100% |
Financials Details(₹ in Crores)
| Particular | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets | 381.76 | 352.12 | 374.06 |
| Revenue | 276.09 | 281.61 | 262.7 |
| Profit After Tax | 10.1 | 3.41 | -2.09 |
| Net Worth | 96.39 | 66.29 | 62.88 |
| Reserve & Surplus | 61.75 | 39.46 | 36.05 |
| Total Borrowings | 196.59 | 205.23 | 215.66 |
Financials Performance
Performance Indicators
EPS Pre
Earnings per share before the IPO.
P/E Pre
IPO Offer Price ÷ EPS Pre.
EPS Post
Expected earnings per share after the IPO..
P/E (Post Issue)
IPO Offer Price ÷ EPS Post.
Amanta Healthcare Ltd KPI Information
| Particular | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|
| ROE % | 12.42 | 5.27 | -3.27 |
| ROCE % | 13.72 | 12.76 | 12.19 |
| Debt / Equity | 2.02 | 3.1 | 3.43 |
| RoNW % | 10.89 | 5.48 | -3.36 |
| Pat Margin % | 3.86 | 1.3 | -0.82 |
Peers Comparison
| Company | Face Value | PE Ratio | EPS Basic | EPS Diluted | RoNW | Net Assets |
|---|---|---|---|---|---|---|
| Amanta Healthcare Ltd | 10 | 0.00 | 1.35 | 1.35 | 5.48 | 24.71 |
| Denis Chem Lab Ltd | 10 | 18.76 | 8.04 | 8.04 | 13.88 | 57.91 |
About Amanta Healthcare Ltd
Incorporated in December 1994, Amanta Healthcare Limited is a pharmaceutical company specializing in the development, manufacturing, and marketing of sterile liquid products. The company focuses on parenteral formulations, packaged using Aseptic Blow-Fill-Seal (ABFS) and Injection Stretch Blow Moulding (ISBM) technologies. It also manufactures a range of medical devices.
Product Portfolio:
Amanta offers a wide range of large volume parenterals (LVPs) and small volume parenterals (SVPs) across six therapeutic segments, including:
- Fluid therapy (IV fluids)
- Diluents
- Ophthalmic solutions
- Respiratory care
- Irrigation solutions
- Medical devices like first-aid solutions and eye lubricants
The company supports various closure systems (nipple head, twist-off, leur-lock, screw types) and container sizes ranging from 2ml to 1000ml.
Business Model:
Amanta operates through three strategic business units:
- National Sales – Selling over 45 generics under its own brands via a network of 320+ distributors and stockists.
- International Sales – Active in Africa, Latin America, the UK, and other regions with product registrations in 19 countries.
- Product Partnering – Manufacturing for other Indian and international pharmaceutical companies, including under loan license agreements.
As of Fiscal 2025, Amanta exported branded products to 21 countries and had 47 products registered across 120 international jurisdictions.
Manufacturing & R&D:
- Location: Hariyala, District Kheda, Gujarat, India
- Facilities: 4 LVP manufacturing lines (ABFS and ISBM), 3 SVP lines (including ABFS and conventional lines)
- Certifications: GMP (India, WHO format), approvals from Cambodia, Sudan, Philippines, Zimbabwe, and DNV certification for medical devices
- Formulation & Development (F&D): In-house lab with modern equipment for developing and improving sterile liquid dosage forms
Therapeutic Categories:
Products cover a range of categories including antibiotics, antifungals, quinolones, diuretics, anti-anaerobics, ophthalmics, and respiratory medications.
Management & Team:
Led by Managing Director Bhavesh Patel, Amanta benefits from a highly experienced and professional management team. As of March 31, 2025, the company employed 123 personnel in its F&D and quality control labs.
Competitive Strengths:
- Well-established manufacturer with a diverse sterile liquid product portfolio
- Strong manufacturing infrastructure with advanced technologies (ABFS, ISBM)
- Wide domestic and international market reach
- Robust product development and regulatory compliance
- Experienced leadership and a skilled, long-serving workforce
Amanta Healthcare IPO Promoters
- Bhavesh Patel
- Vishal Patel
- Jayshreeben Patel
- Jitendra Kumar Patel
- Milcent Appliances Private Limited
Promoters Holding
Holding Pre Issue
85.60%
Holding Post Issue
63.56%
Amanta Healthcare IPO Objective
The company proposes to utilise the Net Proceeds from the Issue towards the following objects:
- Funding capital expenditure requirements for civil construction work and towards the purchase of equipment, plant and machinery for setting up a new manufacturing line of SteriPort at Hariyala, Kheda, Gujarat;
- Funding capital expenditure requirements towards civil construction work, purchase of equipment, plant and machinery for setting up a new manufacturing line for SVP at Hariyala, Kheda, Gujarat; and
- General corporate purposes.
Amanta Healthcare Ltd Address / Contact Details
Amanta Healthcare Limited
8th Floor, Shaligram Corporates,
C.J. Marg, Ambli, Ahmedabad –
380058, Gujarat, India
Phone: 079 67777600
Email: cs@amanta.co.in
Website: https://www.amanta.co.in/
IPO Snapshot
Amanta Healthcare IPO Lot Size
The Amanta Healthcare IPO has a lot size of 119 shares. Retail investors require a minimum investment of ₹14,994 by applying for 1 lot (119 shares). The maximum application allowed for the retail category is 13 lots (1,547 shares), requiring an investment of ₹1,94,922.
| Application | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 119 | 14,994.00 |
| Retail (Max) | 13 | 1,547 | 194,922.00 |
| S-HNI (Min) | 14 | 1,666 | 209,916.00 |
| S-HNI (Max) | 66 | 7,854 | 289,604.00 |
| B-HNI (Min) | 67 | 7,973 | 1,004,598.00 |
Issue Reservation
- — 28.57%
- NII — 21.43%
- RII — 50%
Book Running Lead Managers
- Beeline Capital Advisors Pvt Ltd
IPO Documents & Links
Explore More IPOs
Currently Open
Coming Up Next
Disclaimer: This data is for informational purposes only and does not constitute investment advice.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
What is the Amanta Healthcare IPO?
Amanta Healthcare IPO is a Book-building IPO with a total issue size of ₹126 crore. The Amanta Healthcare IPO price band is ₹120 to 126 per share. The Amanta Healthcare IPO subscription opens on Mon, Sep 1, 2025, and closes on Wed, Sep 3, 2025. The Amanta Healthcare IPO will be listed on the BSE,NSE. MUFG Intime India Private Limited is the registrar for the Amanta Healthcare IPO.
When will the Amanta Healthcare IPO open for subscription?
The Amanta Healthcare IPO opens on Mon, Sep 1, 2025 and closes on Wed, Sep 3, 2025
What is Amanta Healthcare IPO Price Band?
Amanta Healthcare IPO Price Band is ₹120 to 126 per share.
What is Amanta Healthcare IPO Lot Size?
Amanta Healthcare IPO lot size is 119 shares, Retail investors need a minimum investment of ₹14994 based on the upper price band
What is the minimum investment for Amanta Healthcare IPO?
The minimum investment for Amanta Healthcare IPO is ₹14994, based on one lot of 119 shares at the upper price band of ₹126 per share.
How to apply for Amanta Healthcare IPO?
Investors can apply for the Amanta Healthcare IPO through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or through UPI using a SEBI-registered broker or trading app. Select the desired lot size, enter your bid within the price band, and submit the application before Wed, Sep 3, 2025. The application amount remains blocked until the Amanta Healthcare IPO allotment is finalized.
What is Amanta Healthcare IPO Issue Size?
Amanta Healthcare IPO issue size is ₹126 crores.
What is the Amanta Healthcare IPO Allotment Date?
Amanta Healthcare IPO allotment date is Thu, Sep 4, 2025.
Who is the Amanta Healthcare IPO Registrar?
The registrar for Amanta Healthcare IPO is MUFG Intime India Private Limited. Investors can go to MUFG Intime India Private Limited website to check Amanta Healthcare IPO allotment status, refund processing, and other IPO-related information.
What is the Amanta Healthcare IPO GMP?
The Amanta Healthcare IPO GMP (Grey Market Premium) is ₹9 as of Tue, Sep 9, 2025. Based on the upper price band of ₹126 per share, the estimated Amanta Healthcare IPO listing price is ₹135, indicating a potential listing gain of approximately 7.14% over the issue price.
Who is the Amanta Healthcare IPO Lead Manager?
The book-running lead managers (BRLMs) for the Amanta Healthcare IPO are Beeline Capital Advisors Pvt Ltd. The lead managers are responsible for managing the IPO process, including issue structuring, regulatory compliance, marketing the public issue, coordinating with investors, and ensuring a smooth listing process. For complete details, investors should refer to the Amanta Healthcare IPO Red Herring Prospectus (RHP).